Does olanzapine (generic name) cause hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Olanzapine does not directly increase blood pressure, but it can indirectly contribute to hypertension through weight gain and metabolic changes, as noted in studies such as 1 and 1.

Key Points to Consider

  • Olanzapine is known to cause significant weight gain in many patients, which can lead to metabolic syndrome, including insulin resistance and lipid abnormalities, as discussed in 1.
  • These metabolic changes can eventually lead to hypertension in some patients with long-term use, highlighting the importance of regular monitoring of weight, blood pressure, blood glucose, and lipid levels.
  • The typical dosage range for olanzapine is 5-20 mg daily, with treatment often starting at lower doses (2.5-5 mg) and gradually increasing as needed, according to general clinical guidelines.
  • Patients taking olanzapine should be aware of the potential for weight gain and metabolic changes and discuss any significant changes with their healthcare provider, as medication adjustments or additional treatments may be necessary to manage these effects, as suggested in 1 and 1.

Management Strategies

  • Regular monitoring of weight, blood pressure, blood glucose, and lipid levels is crucial for patients taking olanzapine.
  • Lifestyle modifications, such as diet and exercise, can help mitigate the risk of weight gain and metabolic changes.
  • Consideration of alternative antipsychotic medications with lower risk of weight gain and metabolic effects, such as aripiprazole or ziprasidone, may be necessary for some patients, as noted in 1 and 1.

From the FDA Drug Label

Among less commonly reported symptoms were the following potentially medically serious reactions: ... hypertension, and hypotension. The FDA drug label does indicate that hypertension is a potential symptom in cases of olanzapine overdose, suggesting that olanzapine may increase blood pressure in some cases. However, this information is based on postmarketing reports of overdose and not on systematic studies of the drug's effects on blood pressure.

  • Key points:
    • Hypertension is a potential symptom in cases of olanzapine overdose.
    • The relationship between olanzapine and blood pressure is not fully understood based on the provided information.
    • The information provided is based on postmarketing reports of overdose, not systematic studies of the drug's effects on blood pressure 2.

From the Research

Olanzapine and Blood Pressure

  • The relationship between olanzapine and blood pressure is complex, with some studies suggesting an increase in blood pressure, particularly with lower doses 3.
  • A study published in 2022 found that lower doses of olanzapine were associated with an increase in systolic and diastolic blood pressure, whereas higher doses were associated with glucose increases 3.
  • In contrast, a study published in 2009 found that olanzapine treatment did not result in significant changes in systolic and diastolic blood pressure in Korean schizophrenic patients 4.
  • Another study published in 2021 found that olanzapine had a systolic and diastolic blood pressure lowering effect on the first day of treatment in healthy volunteers 5.
  • The effects of olanzapine on blood pressure may be influenced by various factors, including dose, treatment duration, and individual patient characteristics 3, 4, 5.

Comparison with Other Antipsychotics

  • A study published in 2013 found that switching from olanzapine to aripiprazole was associated with larger reductions in predicted 10-year risk of coronary heart disease 6.
  • The same study found that the odds ratio for having metabolic syndrome was higher in patients who stayed on olanzapine compared to those who switched to aripiprazole, although the difference was not statistically significant 6.
  • A study published in 2021 found that olanzapine induced more cardiovascular changes compared to aripiprazole, although more adverse drug reactions were registered for aripiprazole 5.

Individual Variability

  • Genetic polymorphisms may play a role in the development of adverse drug reactions and cardiovascular changes associated with olanzapine treatment 5.
  • Individual patient characteristics, such as age, gender, and medical history, may also influence the effects of olanzapine on blood pressure and cardiovascular risk 3, 4, 5.

Related Questions

Is dose adjustment and lab monitoring necessary for a patient with suspected bipolar 2 disorder on olanzapine and sertraline?
What are the next steps in managing a patient with schizophrenia who has had their Olanzapine (Zyprexa) dose increased from 10mg to 15mg for mood deregulation and their Mirtazapine (Remeron) dose increased to 15mg for insomnia?
What is a suitable initial dose of Abilify (aripiprazole) for a 60-year-old patient?
Can olanzapine increase Blood Urea Nitrogen (BUN) levels?
What is the most appropriate next step in pharmacotherapy for a 56-year-old woman with central nervous system lymphoma, hypertension, type 2 diabetes mellitus, and a history of kidney transplant, presenting with manic symptoms, including elevated mood, grandiose thoughts, and rapid speech, while taking amlodipine, dexamethasone, insulin, melatonin, and tacrolimus (immunosuppressant)?
What underlying process is indicated by a pH of 7.24, partial pressure of carbon dioxide (pCO2) 30, partial pressure of oxygen (pO2) 87, and bicarbonate (HCO3) level of 12, specifically metabolic acidosis with respiratory alkalosis?
What is the underlying process in a patient presenting with chest pain, a history of Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF), with acid-base imbalance indicated by respiratory alkalosis (pH 7.24, partial pressure of carbon dioxide (PCO2) 30, partial pressure of oxygen (PO2) 87, bicarbonate (HCO3) 12)?
What is the underlying process in a patient presenting with chest pain, a history of Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF), with acid-base imbalance indicated by respiratory alkalosis (pH 7.24, partial pressure of carbon dioxide (PCO2) 30, partial pressure of oxygen (PO2) 87, bicarbonate (HCO3) 12)?
What is the treatment for premature ejaculation?
What is the treatment for premature ejaculation?
What are the characteristics of Type 1 and Type 2 respiratory failure on Venous Blood Gas (VBG)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.